|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Loss on early extinguishment of debt | |||||
| Gains on dispositions of properties | |||||
| Depreciation and amortization of deferred leasing costs | |||||
| Amortization of deferred debt costs | |||||
| Non-cash compensation costs of stock and option grants | |||||
| Credit losses on operating lease receivables, net | |||||
| (Increase) decrease in accounts receivable and accrued income | |||||
| Additions to deferred leasing costs | |||||
| Decrease in other assets | |||||
| Increase (decrease) in accounts payable, accrued expenses and other liabilities | |||||
| Increase (decrease) in deferred income | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisitions of real estate investments | |||||
| Acquisition of real estate investments | |||||
| Additions to real estate investments | |||||
| Additions to development and redevelopment projects | |||||
| Proceeds from dispositions of properties | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from mortgage notes payable | |||||
| Repayments on mortgage notes payable | |||||
| Proceeds from term loan facility | |||||
| Proceeds from revolving credit facility | |||||
| Payments for debt extinguishment costs | |||||
| Repayments on revolving credit facility | |||||
| Proceeds from construction loans payable | |||||
| Additions to deferred debt costs | |||||
| Proceeds from the issuance of: | |||||
| Common stock | |||||
| Partnership units | |||||
| Partnership units | |||||
| Distributions to: | |||||
| Distributions to preferred stockholders | |||||
| Series D Cumulative Redeemable Preferred Stock | |||||
| Series E Cumulative Redeemable Preferred Stock | |||||
| Total distributions to preferred stockholders | |||||
| Common stockholders | |||||
| Noncontrolling interests | |||||
| Net cash provided by (used in) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents, beginning of year | |||||
| Cash and cash equivalents, end of year | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Accrued capital expenditures included in accounts payable, accrued expenses, and other liabilities | |||||
Loading...